Literature DB >> 3082663

Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.

N Yoshida.   

Abstract

The complement-dependent lytic activity of various mouse antisera to Trypanosoma cruzi was tested, using purified culture metacyclic trypomastigotes as targets, in an attempt to verify the correlation between resistance to T. cruzi and lytic antibodies, Sera of mice immunized with killed trypomastigotes, which resisted acute infection by insect-derived metacyclics of T. cruzi, consistently lysed over 95% of trypomastigotes in vitro. In contrast, fewer than 50% of parasites were lysed by sera of mice immunized with killed epimastigotes, which, upon challenge with metacyclic forms, developed high parasitemias comparable to those of non-immunized controls. All immune sera with high lytic activity, namely sera of mice immunized with killed trypomastigotes and sera of chronically infected mice, reacted with a set of 131I-labeled trypomastigote surface proteins with apparent molecular weights of 77,000, 82,000, and 88,000, which failed to be recognized by sera of mice immunized with epimastigotes, Absorption of lytic sera with trypomastigotes, but not with epimastigotes, greatly reduced the ability to lyse trypomastigotes and to precipitate the surface polypeptides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082663     DOI: 10.1016/0014-4894(86)90151-7

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

1.  Metacyclic neutralizing effect of monoclonal antibody 10D8 directed to the 35- and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi.

Authors:  N Yoshida; R A Mortara; M F Araguth; J C Gonzalez; M Russo
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

Authors:  B Wizel; N Garg; R L Tarleton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

3.  Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.

Authors:  F Kierszenbaum; M A Ramirez
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.

Authors:  E E Jazín; A O Luquetti; A Rassi; A C Frasch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Efficient expression of a Trypanosoma cruzi antigen in Escherichia coli and Staphylococcus aureus and its rapid purification.

Authors:  J I Moreno; M Seigelchifer; J Zorzópulos
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

6.  Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes.

Authors:  J González; M F Araguth; N Yoshida
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection.

Authors:  R L Cardoni; M E Rottenberg; E L Segura
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

8.  A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection.

Authors:  R Santori F; G S Paranhos-Bacalla; J Franco DA Silveira; L M Yamauchi; J E Araya; N Yoshida
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signaling in mammalian cells.

Authors:  B A Burleigh; E V Caler; P Webster; N W Andrews
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.